| 11/17/2026 8:25 AM | Edesa Biotech (1540159) Filer | Form 8-K Current report pursuant to Section 13 or 15(d) | |
| 11/16/2026 4:04 PM | Edesa Biotech (1540159) Subject PERCEPTIVE ADVISORS LLC (1224962) Filed by | Form SCHEDULE 13G/A | |
| 11/16/2026 3:30 PM | Boxer Capital Management, LLC (2018299) Filed by Edesa Biotech (1540159) Subject | Form SCHEDULE 13G | |
| 11/16/2026 9:01 AM | Edesa Biotech (1540159) Subject STEMPOINT CAPITAL LP (1952142) Filed by | Form SCHEDULE 13G | |
| 11/16/2026 8:12 AM | Edesa Biotech (1540159) Subject Sirenia Capital Management LP (2115022) Filed by | Form SCHEDULE 13G/A | |
| 11/12/2026 8:08 AM | Adage Capital Management, L.P. (1535978) Filed by Edesa Biotech (1540159) Subject | Form SCHEDULE 13G | |
| 11/09/2026 5:05 AM | Edesa Biotech (1540159) Filer | Form 8-K Current report pursuant to Section 13 or 15(d) | |
| 11/05/2026 4:01 PM | Edesa Biotech (1540159) Issuer Nijhawan Pardeep (1777962) Reporting | Form 4 Statement of changes in beneficial ownership of securities | |
| 11/04/2026 4:52 PM | Edesa Biotech (1540159) Subject INTEGRATED CORE STRATEGIES (1319244) US | Form SCHEDULE 13G/A | |
| 10/29/2026 4:02 PM | Edesa Biotech (1540159) Issuer Nijhawan Pardeep (1777962) Reporting | Form 4 Statement of changes in beneficial ownership of securities | |
| 10/23/2026 4:24 PM | Edesa Biotech (1540159) Filer | Form 8-K Current report pursuant to Section 13 or 15(d) | |
Get the Latest News and Ratings for EDSA and Related Stocks Enter your email address below to receive the latest news and analysts' ratings for Edesa Biotech and its competitors with MarketBeat's FREE daily newsletter.
|
| 10/15/2026 8:15 AM | Edesa Biotech (1540159) Filer | Form 8-K Current report pursuant to Section 13 or 15(d) | |
| 10/06/2026 4:05 PM | Edesa Biotech (1540159) Issuer Nijhawan Pardeep (1777962) Reporting | Form 4 Statement of changes in beneficial ownership of securities | |
| 09/01/2026 5:12 PM | Edesa Biotech (1540159) Issuer Nijhawan Pardeep (1777962) Reporting | Form 4 Statement of changes in beneficial ownership of securities | |
| 08/26/2026 3:41 PM | Edesa Biotech (1540159) Subject Stonepine Capital Management, LLC (1440771) Filed by | Form SCHEDULE 13G | |
| 08/25/2026 5:00 PM | Edesa Biotech (1540159) Subject Nijhawan Pardeep (1777962) Filed by | Form SCHEDULE 13D/A | |
| 08/25/2026 3:38 PM | Edesa Biotech (1540159) Subject Velan Capital Investment Management LP (1848809) Filed by | Form SCHEDULE 13D/A | |
| 08/20/2026 3:10 PM | Edesa Biotech (1540159) Filer | Form 424B5 | |
| 08/20/2026 3:15 PM | Edesa Biotech (1540159) Filer | Form 8-K Current report pursuant to Section 13 or 15(d) | |
| 08/19/2026 3:05 PM | Edesa Biotech (1540159) Filer | Form 424B5 | |
| 08/13/2026 3:40 PM | Edesa Biotech (1540159) Filer | Form 10-Q General form for quarterly reports under Section 13 or 15(d) | |
| 08/13/2026 3:20 PM | Edesa Biotech (1540159) Filer | Form 8-K Current report pursuant to Section 13 or 15(d) | |
| 08/04/2026 4:02 PM | Edesa Biotech (1540159) Issuer Nijhawan Pardeep (1777962) Reporting | Form 4 Statement of changes in beneficial ownership of securities | |
| 07/13/2026 11:15 PM | Edesa Biotech (1540159) Filer | Form EFFECT | |
| 07/13/2026 3:15 PM | Edesa Biotech (1540159) Filer | Form 424B3 | |
| 07/02/2026 4:00 PM | Edesa Biotech (1540159) Filer | Form S-3 Registration statement under Securities Act of 1933 | |
| 07/02/2026 4:05 PM | Edesa Biotech (1540159) Issuer Nijhawan Pardeep (1777962) Reporting | Form 4 Statement of changes in beneficial ownership of securities | |
| 06/26/2026 4:05 PM | Edesa Biotech (1540159) Filer | Form D Notice of Exempt Offering of Securities | |
| 06/18/2026 4:05 PM | Edesa Biotech (1540159) Subject INTEGRATED CORE STRATEGIES (0) US | Form SCHEDULE 13G | |
| 06/16/2026 4:03 PM | Edesa Biotech (1540159) Issuer Nijhawan Pardeep (1777962) Reporting | Form 4 Statement of changes in beneficial ownership of securities | |
| 06/16/2026 4:06 PM | Edesa Biotech (1540159) Subject Nijhawan Pardeep (1777962) Filed by | Form SCHEDULE 13D/A | |
| 06/11/2026 8:20 AM | Edesa Biotech (1540159) Filer | Form 8-K Current report pursuant to Section 13 or 15(d) | |
| 06/05/2026 8:25 AM | Edesa Biotech (1540159) Filer | Form 8-K Current report pursuant to Section 13 or 15(d) | |
| 06/01/2026 4:00 PM | Edesa Biotech (1540159) Issuer Nijhawan Pardeep (1777962) Reporting | Form 4 Statement of changes in beneficial ownership of securities | |
| 05/29/2026 4:00 PM | Edesa Biotech (1540159) Issuer Liu Da David (2054265) Reporting | Form 4 Statement of changes in beneficial ownership of securities | |
| 05/29/2026 4:00 PM | Edesa Biotech (1540159) Issuer Nijhawan Pardeep (1777962) Reporting | Form 4 Statement of changes in beneficial ownership of securities | |
| 05/29/2026 4:00 PM | Edesa Biotech (1540159) Issuer Olson Charles V (1663298) Reporting | Form 4 Statement of changes in beneficial ownership of securities | |
| 05/29/2026 4:01 PM | Edesa Biotech (1540159) Issuer Sistilli Carlo (1777988) Reporting | Form 4 Statement of changes in beneficial ownership of securities | |
| 05/29/2026 4:01 PM | Brooks Michael J (1779126) Reporting Edesa Biotech (1540159) Issuer | Form 4 Statement of changes in beneficial ownership of securities | |
| 05/29/2026 4:01 PM | Edesa Biotech (1540159) Issuer Weiler Peter J. (2066576) Reporting | Form 4 Statement of changes in beneficial ownership of securities | |
| 05/29/2026 4:01 PM | Chypyha Joan (1978315) Reporting Edesa Biotech (1540159) Issuer | Form 4 Statement of changes in beneficial ownership of securities | |
Beyond NVDA: The World’s Next #1 Company? (Ad) This small-cap trades in an overlooked corner of the market, with a market cap more than 600X smaller than Nvidia's.
A NASA scientist says the technology behind it is bigger than AI. Musk calls it "Amazing," and a Nobel Prize winner describes its power as "unprecedented in the history of life on Earth."
Adam O'Dell, Chief Investment Strategist at Money and Markets, names the company at the center of it all. Discover the small-cap company at the center of this tech revolution. |
| 05/29/2026 4:02 PM | Edesa Biotech (1540159) Issuer MacDonald Sean Arthur (1778981) Reporting | Form 4 Statement of changes in beneficial ownership of securities | |
| 05/29/2026 4:02 PM | Edesa Biotech (1540159) Issuer Marshall Patrick (1978257) Reporting | Form 4 Statement of changes in beneficial ownership of securities | |
| 05/29/2026 3:43 PM | Edesa Biotech (1540159) Filer | Form S-8 Registration statement under Securities Act of 1933 to be offered to employees pursuant to certain plans | |
| 05/29/2026 3:15 PM | Edesa Biotech (1540159) Filer | Form 8-K Current report pursuant to Section 13 or 15(d) | |
| 05/15/2026 4:15 PM | Edesa Biotech (1540159) Subject Stonepine Capital Management, LLC (1440771) Filed by | Form SCHEDULE 13G/A | |
| 05/15/2026 3:03 PM | Edesa Biotech (1540159) Subject Rubric Capital Management LP (1687509) Filed by | Form SCHEDULE 13G | |
| 05/15/2026 8:08 AM | Edesa Biotech (1540159) Filer | Form 8-K Current report pursuant to Section 13 or 15(d) | |
| 05/15/2026 7:14 AM | Edesa Biotech (1540159) Subject Sirenia Capital Management LP (2115022) Filed by | Form SCHEDULE 13G | |
| 05/14/2026 3:40 PM | Edesa Biotech (1540159) Filer | Form 8-K Current report pursuant to Section 13 or 15(d) | |
| 05/14/2026 3:50 PM | Edesa Biotech (1540159) Filer | Form 10-Q General form for quarterly reports under Section 13 or 15(d) | |
| 05/01/2026 8:01 PM | Edesa Biotech (1540159) Issuer Nijhawan Pardeep (1777962) Reporting | Form 4 Statement of changes in beneficial ownership of securities | |
| 04/10/2026 4:02 PM | Edesa Biotech (1540159) Issuer Nijhawan Pardeep (1777962) Reporting | Form 4 Statement of changes in beneficial ownership of securities | |
| 04/03/2026 3:35 PM | Edesa Biotech (1540159) Filer | Form ARS | |
| 04/03/2026 3:31 PM | Edesa Biotech (1540159) Filer | Form DEF 14A | |
| 04/03/2026 3:33 PM | Edesa Biotech (1540159) Filer | Form DEFA14A | |
| 03/16/2026 3:00 PM | Edesa Biotech (1540159) Subject PERCEPTIVE ADVISORS LLC (1224962) Filed by | Form SCHEDULE 13G | |
| 03/11/2026 4:02 PM | Brooks Michael J (1779126) Reporting Edesa Biotech (1540159) Issuer | Form 4 Statement of changes in beneficial ownership of securities | |
| 03/10/2026 4:02 PM | Edesa Biotech (1540159) Issuer Nijhawan Pardeep (1777962) Reporting | Form 4 Statement of changes in beneficial ownership of securities | |
| 03/02/2026 6:03 PM | Edesa Biotech (1540159) Subject Velan Capital Investment Management LP (1848809) Filed by | Form SCHEDULE 13D/A | |
| 03/02/2026 4:01 PM | Edesa Biotech (1540159) Issuer Nijhawan Pardeep (1777962) Reporting | Form 4 Statement of changes in beneficial ownership of securities | |
| 03/02/2026 4:05 PM | Edesa Biotech (1540159) Issuer Nijhawan Pardeep (1777962) Reporting | Form 4 Statement of changes in beneficial ownership of securities | |
| 02/24/2026 8:21 AM | Edesa Biotech (1540159) Filer | Form 8-K Current report pursuant to Section 13 or 15(d) | |
| 02/13/2026 3:45 PM | Edesa Biotech (1540159) Filer | Form 10-Q General form for quarterly reports under Section 13 or 15(d) | |
| 01/05/2026 8:00 PM | Edesa Biotech (1540159) Issuer Nijhawan Pardeep (1777962) Reporting | Form 4 Statement of changes in beneficial ownership of securities | |
| 12/12/2025 3:40 PM | Edesa Biotech (1540159) Filer | Form 424B5 | |
| 12/12/2025 3:45 PM | Edesa Biotech (1540159) Filer | Form 8-K Current report pursuant to Section 13 or 15(d) | |
| 12/12/2025 3:25 PM | Edesa Biotech (1540159) Filer | Form 8-K Current report pursuant to Section 13 or 15(d) | |
| 12/12/2025 3:30 PM | Edesa Biotech (1540159) Filer | Form 10-K Annual report pursuant to Section 13 or 15(d) | |
| 12/02/2025 5:01 PM | Edesa Biotech (1540159) Issuer Nijhawan Pardeep (1777962) Reporting | Form 4 Statement of changes in beneficial ownership of securities | |